February 25, 2026: The Breakthrough
The longest shutdown in the SBIR and STTR programs' 43-year history is ending. On February 25, 2026, Senator Joni Ernst (R-Iowa), Chair of the Senate Small Business and Entrepreneurship Committee, and Senator Ed Markey (D-Massachusetts), the Ranking Member, announced a bipartisan deal: the Small Business Innovation and Economic Security Act. The bill was immediately hot-lined in the Senate — a procedural move that positions it for rapid passage via unanimous consent. The deal caps nearly five months of negotiations that began when Ernst blocked the House's clean one-year extension (H.R. 5100) on the Senate floor on September 30, 2025. The programs formally lapsed at midnight on October 1, freezing all new solicitations and awards across 11 federal agencies. Several factors drove the final compromise. Pentagon officials reportedly threatened to redirect SBIR funding entirely if reauthorization did not happen quickly. Space Force acquisition leaders publicly warned that critical satellite communications and adversary-detection technologies were stalled. The Department of Education's SBIR program nearly collapsed entirely after mass layoffs reduced staff from 4,100 to 2,200, with all three SBIR program managers let go. And thousands of small businesses — over 4,000 per year typically receive awards — had no new opportunities for almost half a year. Senator Markey did not mince words: "I am disappointed at the unnecessary suffering that was caused by the programs' longest shut down in their history." The National Small Business Association called the deal a moment to applaud, saying it would "get the 4,000+ companies per year who innovate, create jobs and harness vital technology for the federal government back on track."
What the Compromise Bill Does
The Small Business Innovation and Economic Security Act extends the SBIR and STTR programs through September 30, 2031 — a five-and-a-half-year authorization from the lapse date. It includes several structural reforms that reflect compromises between Ernst's push for accountability and Markey's defense of program scale. The $75 million lifetime cap is gone. Ernst's original INNOVATE Act (S. 853) proposed capping the total Phase I and Phase II funding any single company could receive over its lifetime at $75 million. This was the most contentious provision in the entire debate, with critics arguing it would "kneecap research and development firms." The compromise dropped the cap entirely in favor of annual proposal limits. Proposal caps begin in fiscal year 2027. Instead of limiting how much money a company can receive, the bill limits how many proposals a company can submit per fiscal year, per solicitation, or per topic. The specific limits are set by each agency's SBIR program director. Waivers are available on a topic-by-topic basis for "time-sensitive and urgent" needs, but the waiver process requires written justification, a 15-day approval clock with senior officials, and is limited to no more than 5 percent of topics per fiscal year. A new Strategic Breakthrough Phase II category allows jumbo awards up to $30 million per project for up to 48 months. These are designed to bridge the "valley of death" between lab research and real-world deployment. Companies must have at least one prior Phase II award to be eligible and must provide matching funds: a minimum of 100 percent from non-SBIR sources. For DoD, the match is even steeper — 200 percent, with at least 20 percent from new non-SBIR DoD funding. The program is funded from up to 0.50 percent of each agency's extramural R&D budget. Foreign risk screening is strengthened and standardized across all agencies. Applicants are screened for cybersecurity practices, patent analysis, employee backgrounds, foreign ownership ties, and relationships with "foreign countries of concern" — defined as China, North Korea, Russia, Iran, and others designated by the Secretary of State. Importantly, a security-based denial does not permanently bar future eligibility; agencies must notify firms and allow them to address concerns. Phase III gets a boost. The bill mandates training for contracting officers on Phase III agreements, data rights, and sole-source execution. It encourages Procurement Center Representatives to utilize Phase III and promotes standardized model contracts across all phases. This matters because Phase III — where SBIR technologies get purchased by the government using non-SBIR funds — has historically been underutilized due to contracting officer unfamiliarity. Technical and business assistance (TABA) is expanded. Cybersecurity assistance and employee training are now eligible expenses. Commercialization assistance amounts are set at up to $6,500 per Phase I project and $50,000 per Phase II award. Participation in NSF's I-Corps commercialization program is explicitly made eligible. Data tracking is enhanced. The federal SBIR database will add fields for classified awards, direct-to-Phase II designations, strategic breakthrough awards, and Phase III awards. Contracting officers must reference prior SBIR contract ID numbers for all follow-on work, creating a traceable chain from first award to deployment.
🔍 Search related opportunities now
How We Got Here: The Five-Month Lapse
The timeline tells the story of how a routine reauthorization became the longest shutdown in program history. On September 15, 2025, the House passed H.R. 5100 unanimously — a clean one-year extension with no programmatic changes. Two weeks later, on September 30, Senator Markey requested unanimous consent to pass H.R. 5100 in the Senate. Senator Ernst objected, demanding structural reforms. At midnight on October 1, the programs lapsed. All new solicitations froze. Through October and November, agencies scrambled. NIH issued NOT-OD-26-006, formally terminating all 24 SBIR/STTR funding opportunities across its institutes. NSF paused its America's Seed Fund program. DoD's Space Force postponed three small-business contracts for satellite communications and warning payloads through SpaceWERX. The FY2026 National Defense Authorization Act, signed December 18, was considered the best vehicle for reauthorization. It passed without SBIR provisions. The Armed Services Committees required sign-off from the bipartisan leadership of the House and Senate Small Business Committees plus the House Science Committee. No agreement was reached. The January 30, 2026 continuing resolution passed without reauthorization language. By this point, the lapse was four months old. In early February, the situation deteriorated further. The Department of Education underwent mass layoffs that eliminated all three staff members running its SBIR program. A dozen current SBIR awardees signed an open letter to Congress. UNC Research's federal update on February 18 confirmed the programs remained lapsed with no resolution in sight. Then, around February 24, Pentagon officials reportedly made clear they would redirect SBIR funding if Congress did not act. Within 48 hours, Ernst and Markey announced their deal.
The Core Disagreements and How They Were Resolved
The debate came down to several fundamental questions about the programs' future. The compromise addressed each one. Lifetime caps versus proposal limits: Ernst's original INNOVATE Act proposed a $75 million lifetime cap on SBIR funding per company, targeting firms she called "SBIR mills" — organizations that win large numbers of awards without demonstrating commercial outcomes. A GAO study found that 22 companies received 50 or more Phase II awards between 2011 and 2020, accounting for roughly 10 percent of Phase II dollars despite being less than 1 percent of awardees. Critics argued hard caps would penalize success. Resolution: The lifetime cap was dropped. Instead, the bill uses annual proposal caps set by each agency, with a strict waiver process. This limits submission volume without punishing companies that win awards and commercialize successfully. Program permanence versus sunset clauses: Markey's bill (S. 1573) would have made the programs permanent, ending the recurring reauthorization cycle. Ernst insisted on a time-limited authorization to preserve congressional leverage for future reforms. Resolution: The programs are extended through September 30, 2031 — a five-and-a-half-year window. Not permanent, but long enough to provide stability. Program size: Democrats wanted to more than double the SBIR set-aside from 3.2 to 7 percent. Ernst's INNOVATE Act proposed a modest increase to 3.45 percent. Resolution: The compromise does not dramatically change the set-aside percentages. Instead, it creates the new Strategic Breakthrough Awards funded from a separate 0.50 percent of extramural R&D budgets, effectively expanding program funding without restructuring the core set-aside. Foreign influence screening: This was the area of greatest bipartisan agreement from the start. All proposals strengthened screening. A May 2025 Senate investigation found that 10 agencies either failed to flag risky applications or denied very few relative to the number flagged. Resolution: Comprehensive standardized screening with a notice-and-cure process so companies can address concerns rather than being permanently blacklisted. Venture capital participation: Since 2011, some agencies have allowed majority-VC-owned firms to receive SBIR awards. No single VC, hedge fund, or private equity firm may own more than 50 percent of the business. A company may be more than 50 percent owned by multiple VCs combined. Only DoD and HHS have actually made such awards in recent years. The compromise bill does not significantly change these rules based on available information. DOGE alignment: Ernst's reforms were described in some coverage as aiming to "DOGE-ify" the SBIR/STTR programs. The emphasis on Phase III procurement, reduced administrative overhead, faster technology deployment, and accountability for outcomes aligns with the current administration's efficiency agenda. SBIR Phase III is particularly well-positioned because it allows sole-source contracting, bypassing traditional competitive procurement.
Current Status by Agency
As of February 26, 2026, no agency has resumed issuing new SBIR or STTR solicitations. That will change once the bill is signed into law. Here is where each agency stands. NIH (National Institutes of Health): Fully suspended. NIH issued NOT-OD-26-006 on November 17, 2025, terminating all SBIR/STTR funding opportunities effective October 1. Twenty-four specific NOFOs expired across NHLBI, NINDS, NIAID, NEI, and other institutes. Applications that were due January 5, 2026 were not accepted. Noncompeting continuation awards are suspended until reauthorization. Separately, NIH ended traditional paylines for 2026 funding — a methodological shift unrelated to the lapse but compounding uncertainty for applicants. NSF (National Science Foundation): Paused submission of new Project Pitches to the America's Seed Fund SBIR/STTR program. Program Directors continue processing previously received pitches. Contact sbir@nsf.gov for status updates. DoD (Department of Defense): Most affected by the lapse in practical terms. Space Force postponed three small-business contracts through SpaceWERX for satellite communications and warning payload technologies — including sensors that detect adversary tracking radars, laser detection systems, and approaching spacecraft sensors. A planned solicitation for "agile" satellite busses for surveillance and orbital warfare is in a holding pattern. AFWERX and SpaceWERX paused new solicitations. Some pre-October 1 rolling topics may still be open at defensesbirsttr.mil. Pentagon officials' threat to redirect SBIR funding was reportedly the catalyst for the final deal. DOE (Department of Energy): FY 2026 Phase I Release 1 topics experienced a "slight delay" initially but are now indefinitely postponed. When solicitations resume, expect policy shifts: greater emphasis on fossil-related technologies and nuclear energy, reduced focus on renewables and hydrogen. Section 309 of Energy and Water appropriations gives DOE flexibility to reprogram SBIR/STTR funds within R&D accounts. NASA: Had planned a significant shift to a Broad Agency Announcement format for 2026, with multiple submission windows. That plan is on hold. DHS (Department of Homeland Security): Clarified that Phase III follow-on work remains available regardless of the lapse. Phase III is not funded with SBIR dollars and may proceed using non-SBIR funds and other contracting authorities. This is an important distinction for any company with existing awards. Department of Education: In crisis. Mass layoffs reduced the department from approximately 4,100 to 2,200 employees, and all three staff members managing the SBIR program at the Institute for Education Sciences were let go. A dozen current SBIR awardees signed an open letter to Congress. IES Commissioner Elizabeth Albro acknowledged the institute was "deeply impacted." Education's SBIR program had demonstrated a 9:1 rate of return on investment from 2012 to 2022. Whether the program can continue at all is an open question. USDA, EPA, DOT, Commerce (NOAA, NIST), and other participating agencies: No 2026 solicitations issued.
Impact on the Innovation Ecosystem
The programs collectively represent over $5 billion annually in small business R&D funding. In fiscal year 2022, agencies obligated approximately $4.4 billion in SBIR awards and $662 million in STTR awards across 11 participating agencies. The five-month lapse has had cascading effects. Thousands of small businesses that depend on SBIR as a primary R&D funding source had no new opportunities to apply for. Companies that were preparing applications for fiscal year 2026 solicitations had no submission targets. Small R&D firms that plan staffing around expected SBIR awards implemented hiring freezes or reductions. The defense impact has been particularly acute. Kelly Hammett, head of the Space Rapid Capabilities Office, described the situation bluntly: "We've already gone through the [request for proposals], the evaluation. We've been waiting for months to award these contracts through SpaceWERX." Technologies for detecting adversary space threats were delayed at a time of growing competition with China and Russia. The academic pipeline has also suffered. SBIR Phase I and Phase II awards serve as critical bridge funding for technologies between basic research and commercialization — the so-called "valley of death." University spinouts that typically transition to SBIR funding after initial research grants faced a broken pathway. Agency capacity is another concern. SBIR program offices staff up around solicitation cycles. A sustained lapse risks losing experienced program managers and technical reviewers who move to other roles. Rebuilding that capacity takes time. The Department of Education's situation is an extreme example, but other agencies face similar if less severe attrition. The lapse does not affect existing awards. Companies with active Phase I, II, or III awards continue under their current terms. Phase III commercialization work, funded by non-SBIR sources, also continues. DHS explicitly confirmed this.
What Happens Next
The deal is done but the legislative process is not finished. Here is the expected timeline. The bill was hot-lined in the Senate on February 25, meaning it is positioned for passage via unanimous consent without a roll-call vote. This could happen within days. The Small Business Technology Coalition (SBTC) indicated the bill is expected to move to the House the following week. House passage is considered highly likely. The House already passed a clean extension (H.R. 5100) unanimously in September, demonstrating strong bipartisan support. The compromise bill includes reforms that both sides wanted, making opposition unlikely. After House passage, the bill goes to the President's desk. Given the bipartisan nature of the deal and the administration's stated interest in DOGE-aligned procurement efficiency, a presidential signature is expected. Once signed, agencies will restart solicitations and award processes. Expect a burst of activity as agencies release backlogged topics and solicitations. Companies with prepared proposals will have an advantage. The proposal cap rules do not take effect until fiscal year 2027, giving companies and agencies a full year to adjust. Strategic Breakthrough Awards will require agencies to develop new evaluation criteria and matching-fund verification processes, likely taking several months to implement. The bill extends programs through September 30, 2031. Congress will need to reauthorize again before that date, but the five-and-a-half-year window provides meaningful stability for planning purposes.
What Small Businesses Should Do Right Now
The end of the lapse is in sight. The next few weeks are the time to prepare. Prepare your proposals now. When agencies resume solicitations, they will likely fast-track new topics. Companies with polished proposals, current registrations, and ready budgets will be first in line. Draft your technical approach, commercialization plan, and budget while waiting. If you have previously submitted to a specific agency, review their format requirements — some may change under the new bill. Verify your SAM.gov registration is current. Renewals take time, and an expired registration blocks all federal applications. If your registration lapsed during the shutdown, start the renewal process immediately. Understand the new proposal caps. Starting in FY2027, each agency will set limits on how many proposals you can submit per fiscal year, per solicitation, or per topic. If you typically submit a high volume of proposals across multiple agencies, plan your strategy now. Focus on your strongest opportunities. Explore Strategic Breakthrough Awards. If you have a completed Phase II and can secure matching funds, the new up-to-$30-million awards could be transformative. Start identifying potential matching-fund sources: private investors, strategic corporate partners, non-SBIR government contracts, or state innovation programs. Review your foreign risk profile. The new screening requirements are comprehensive. If your company has any foreign ownership, employee ties to countries of concern, or international patent arrangements, prepare documentation proactively. A denial is not permanent, but addressing concerns before they arise is faster. If you have an existing award, your funding continues. Phase III follow-on work remains available. Contact your Program Officer for guidance specific to your award and agency. For companies that cannot wait, alternatives remain available. Federal contracts with small business set-asides are fully operational on SAM.gov. Broad Agency Announcements, Other Transaction Authorities, and direct research contracts from DARPA, ARPA-H, and other agencies continue. State innovation programs and foundation grants are unaffected. See our companion guide on R&D contracts beyond SBIR for details. Stay informed. The Small Business Technology Coalition (SBTC) and National Small Business Association (NSBA) provide regular legislative updates. Follow their channels for the latest on the bill's progress through Congress. Search Funding Landscape for open opportunities that match your technology area. We track SBIR/STTR alongside thousands of other federal, state, and foundation funding programs.